| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | 0.2 | 3e-08 |
| mRNA | BYL-719 | CTRPv2 | pan-cancer | AAC | 0.21 | 4e-07 |
| mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | 0.18 | 9e-07 |
| mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | 0.25 | 3e-06 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | 0.16 | 3e-05 |
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | 0.18 | 6e-05 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.21 | 7e-05 |
| mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0004 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0007 |
| mRNA | BIBR-1532 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |